<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8704773</journal-id><journal-id journal-id-type="pubmed-jr-id">1656</journal-id><journal-id journal-id-type="nlm-ta">Am J Prev Med</journal-id><journal-id journal-id-type="iso-abbrev">Am J Prev Med</journal-id><journal-title-group><journal-title>American journal of preventive medicine</journal-title></journal-title-group><issn pub-type="ppub">0749-3797</issn><issn pub-type="epub">1873-2607</issn></journal-meta><article-meta><article-id pub-id-type="pmid">33975768</article-id><article-id pub-id-type="pmc">8217248</article-id><article-id pub-id-type="doi">10.1016/j.amepre.2021.02.009</article-id><article-id pub-id-type="manuscript">NIHMS1688302</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Easing Human Papillomavirus Vaccine Hesitancy: A Communication
Experiment With U.S. Parents</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Parth D.</given-names></name><degrees>PharmD, PhD</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Calo</surname><given-names>William A.</given-names></name><degrees>PhD, JD</degrees><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gilkey</surname><given-names>Melissa B.</given-names></name><degrees>PhD, MPH</degrees><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Margolis</surname><given-names>Marjorie A.</given-names></name><degrees>MSPH</degrees><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Dailey</surname><given-names>Susan Alton</given-names></name><degrees>MSW, MPH</degrees><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Todd</surname><given-names>Karen</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="A6">6</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Brewer</surname><given-names>Noel T.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Hutchinson Institute for Cancer Outcomes Research, Public
Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle,
Washington;</aff><aff id="A2"><label>2</label>Department of Public Health Sciences, Penn State College of
Medicine, Hershey, Pennsylvania;</aff><aff id="A3"><label>3</label>Penn State Cancer Institute, Hershey, Pennsylvania;</aff><aff id="A4"><label>4</label>Department of Health Behavior, Gillings School of Global
Public Health, University of North Carolina, Chapel Hill, North Carolina;</aff><aff id="A5"><label>5</label>Lineberger Comprehensive Cancer Center, University of North
Carolina, Chapel Hill, North Carolina;</aff><aff id="A6"><label>6</label>Public Health Leadership Program, Gillings School of Global
Public Health, University of North Carolina, Chapel Hill, North Carolina;</aff><aff id="A7"><label>7</label>SAFEchild Advocacy Center, Raleigh, North Carolina</aff><author-notes><corresp id="CR1">Address correspondence to: Parth D. Shah, PharmD, PhD, Hutchinson
Institute for Cancer Outcomes Research, Public Health Sciences Division, Fred
Hutchinson Cancer Research Center, 1100 Fairview Ave. N, Mailstop M3-B232,
Seattle WA 98109. <email>pshah@fredhutch.org</email>.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>1</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>08</day><month>5</month><year>2021</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>7</month><year>2022</year></pub-date><volume>61</volume><issue>1</issue><fpage>88</fpage><lpage>95</lpage><!--elocation-id from pubmed: 10.1016/j.amepre.2021.02.009--><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">The Announcement Approach using presumptive announcements increases
human papillomavirus (HPV) vaccine uptake. This study seeks to understand
the impact of the final Announcement Approach steps, easing parents&#x02019;
vaccine concerns and then encouraging them to get HPV vaccine for their
children, on parents&#x02019; HPV vaccine hesitancy and confidence in the
vaccine&#x02019;s benefits.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">In 2017&#x02013;2018, investigators recruited an online national
sample of 1,196 U.S. parents of children aged 9&#x02013;17 years who had not
yet completed the HPV vaccine series. Following the steps of the
Announcement Approach, participants viewed brief videos of a pediatrician
announcing the child was due for HPV vaccine (shown to all parents). In the
2 &#x000d7; 2 experiment, parents saw: (1) a video of the pediatrician
attempting to ease a concern the parent had raised earlier in the survey
(Ease video), (2) a video of the pediatrician encouraging the parent to get
their child vaccinated (Encourage video), (3) both videos, or (4) neither
video. Data analysis was conducted in spring 2020.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Seeing the Ease video message led to lower HPV vaccine hesitancy
compared with not seeing it (mean=2.71, SD=1.29 vs mean=2.97, SD=1.33;
<italic>p</italic>&#x0003c;0.001). The beneficial impact of easing
concerns on lower vaccine hesitancy was explained by higher confidence
(<italic>p</italic>&#x0003c;0.05). By contrast, the Encourage video had
no impact on HPV vaccine hesitancy or confidence.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Addressing parents&#x02019; concerns can decrease HPV vaccine
hesitancy and increase confidence. Based on these findings, the Announcement
Approach retained its emphasis on announcing children are due for
vaccination and easing parent concerns.</p></sec></abstract></article-meta></front><body><sec id="S5"><title>INTRODUCTION</title><p id="P5">Human papillomavirus (HPV) vaccine series completion in the U.S. was 54%
among adolescents aged 13&#x02013;17 years in 2019,<sup><xref rid="R1" ref-type="bibr">1</xref></sup> far below the <italic>Healthy People
2020</italic> goal of 80%.<sup><xref rid="R2" ref-type="bibr">2</xref></sup>
Coverage may be even lower given the drop in childhood vaccine uptake during the
coronavirus disease 2019 (COVID-19) pandemic,<sup><xref rid="R3" ref-type="bibr">3</xref></sup> potentially undoing progress made for adolescent vaccination
over the past 14 years. Additionally, the WHO identified vaccine hesitancy as a top
10 threat to global health,<sup><xref rid="R4" ref-type="bibr">4</xref></sup> adding
new urgency to vaccine hesitancy interventions. Vaccine hesitancy is a motivational
state of being conflicted about or opposed to getting vaccinated and is a key
predictor of vaccine uptake.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> To
date, RCTs have identified that using a presumptive communication approach, wherein
providers assume parents are ready to vaccinate their children, elicits higher
uptake of HPV<sup><xref rid="R6" ref-type="bibr">6</xref>&#x02013;<xref rid="R8" ref-type="bibr">8</xref></sup> and other vaccines.<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup>
However, few studies have examined the effect of subsequent vaccine communication on
parents&#x02019; HPV vaccine hesitancy after the presumptive statement.</p><p id="P6">The Announcement Approach is an evidence-based communication strategy shown
to increase HPV vaccine uptake in primary care clinics.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> As of 2017, training on the approach
suggested 3 steps: (1) start with a presumptive announcement stating the child is
due for HPV vaccination and will receive it at the end of their health visit, (2)
ease parents&#x02019; questions or concerns about vaccination, and (3) encourage HPV
vaccination. As of 2019, &#x0003e;1,700 healthcare professionals in the U.S. and
England have attended Announcement Approach trainings.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> The training is recognized by the National
Cancer Institute as an Evidence-Based Cancer Control Program.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> However, the trial evaluating the training
isolated the benefit of the Announcement Approach&#x02019;s use of presumptive
announcements for raising the topic of vaccination.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Little is known about the effect of the
Approach&#x02019;s later steps. Identifying active intervention components<sup><xref rid="R13" ref-type="bibr">13</xref></sup> in the Announcement Approach can
support changes to optimize the communication intervention so that it is easier to
teach, more memorable to vaccine providers, and more likely to be used in clinical
encounters. This paper reports the findings of a national experiment that evaluated
the second and third steps of the Announcement Approach. The authors predicted that
parents exposed to the Ease step would report lower HPV vaccine hesitancy, have
higher vaccine confidence, and perceive that the physician made a stronger
recommendation to get their child HPV vaccine compared with parents who were not
exposed. The authors predicted a similar benefit of the Encourage step.</p></sec><sec id="S6"><title>METHODS</title><sec id="S7"><title>Study Population</title><p id="P7">Participants were U.S. parents who were members of an existing, national
online probability panel of 60,000 non-institutionalized adults maintained by
GfK (now Ipsos).<sup><xref rid="R14" ref-type="bibr">14</xref></sup> The company
used address-based, probability-sampling to build a panel representative of U.S.
adults.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> A core
profile survey on sociodemographic characteristics allows the company to
identify target populations within the panel. Eligible respondents for the
survey were parents of children aged 9&#x02013;17 years who either had received 0
or 1 dose of HPV vaccine. Parents with &#x0003e;1 eligible child answered survey
items about the child with the most recent birthday. From November 2017 to
January 2018, the company contacted a randomly selected sample of 2,857 parents
from the panel via e-mail. Of these parents, 1,834 parents responded by visiting
the website for the survey and confirmed eligibility, and 1,313 parents (72%)
met eligibility criteria, provided informed consent, and completed some portion
of the survey. After excluding 50 panelists who did not complete at least two
thirds of the survey and 30 parents who did not provide data for key variables,
the surveyed sample contained 1,233 parents. The response rate was 61%, based on
American Association for Public Research Response Rate 4 (<xref rid="SD1" ref-type="supplementary-material">Appendix 1</xref>).<sup><xref rid="R15" ref-type="bibr">15</xref></sup> The authors excluded 37 parents unable
to properly view the video messages to arrive at a final analytic sample of
1,196 parents (<xref rid="SD1" ref-type="supplementary-material">Appendix
2</xref>). Survey non-responders and excluded parents did not differ from
the analytic sample on key sociodemographic characteristics (all
<italic>p</italic>&#x0003e;0.05). Parents were aged 43 years on average,
mostly identified as non-Hispanic White (70%), and had at least some college
education (73%) (<xref rid="T1" ref-type="table">Table 1</xref>). Index children
were aged 13 years on average, and most had not initiated HPV vaccination
(60%).</p></sec><sec id="S8"><title>Experimental procedures</title><p id="P8">The experiment used a 2 &#x000d7; 2 between-subjects factorial design in
which parents saw brief videos of a board-certified female pediatrician (KT)
recommending HPV vaccination. The videos followed the steps suggested by the
Announcement Approach for recommending adolescent vaccines.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> The scripts for all video messages are in
<xref rid="SD1" ref-type="supplementary-material">Appendix 3</xref>. All
participants first saw the Announcement video. Then, the survey software
randomly assigned parents to receive an Ease video, the Encourage video, both
videos, or neither videos. After viewing the videos, participants responded to
several questions assessing the outcomes of interest. The survey did not
evaluate these outcomes prior to participants viewing the videos in order to
avoid a testing by treatment interaction.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p><p id="P9">All participants first saw a video in which the pediatrician announced
the child was due for vaccines routinely recommended at the child&#x02019;s age.
The script for the Announce Step read: <disp-quote id="Q1"><p id="P10">At your child&#x02019;s age, children are due for vaccines
against meningitis, HPV cancers, and whooping cough. We will give the
vaccines that your child is due for at the end of today&#x02019;s
visit.</p></disp-quote></p><p id="P11">Next, participants assigned to see the Ease Step video watched the
pediatrician address an HPV vaccine topic. Because most parents expressed
interest in &#x0003e;1 of the 7 potential topics, the survey software selected
the topic at random, attempting to match their interests. Most parents (92%)
wanted to learn more about the topic to which they were randomly assigned. Then,
software randomly assigned the parent to view 1 of 4 possible videos that
addressed that topic. The authors developed these messages in the videos from a
library of 267 unique messages identified in existing HPV vaccination
educational materials.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> To
develop these brief messages used in the videos, the authors used an iterative
process that included several rounds of consultations with health communication
scientists and vaccine-prescribing physicians, and then text refinements to
produce brief messages accessible to people with lower educational attainment.
To better understand elements of the messages that made them effective (e.g.,
use of the word &#x0201c;cancer&#x0201d;), a separate study used the same analytic
sample as this experiment.<sup><xref rid="R18" ref-type="bibr">18</xref></sup>
Example script of one of the Ease videos read: <disp-quote id="Q2"><p id="P12">I hear you. You&#x02019;re wondering about the diseases that the
HPV vaccine can prevent. HPV infection can cause cancer in both men and
women. The HPV vaccine will protect your child from many of these
cancers.</p></disp-quote></p><p id="P13">Finally, participants assigned to the Encourage video watched the
pediatrician advise them to get their child HPV vaccine. The video was informed
by the authors&#x02019; previous research on recommendation quality<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup>: strongly endorsing HPV vaccine, highlighting cancer
prevention, and encouraging same-day vaccination. The script for the video read:
<disp-quote id="Q3"><p id="P14">I strongly believe in the importance of this cancer-preventing
vaccine for your child. I recommend your child get the HPV vaccine
today.</p></disp-quote></p><p id="P15">The University of North Carolina IRB approved the experimental protocol.
A protocol was not pre-registered for this study.</p></sec><sec id="S9"><title>Measures</title><p id="P16">This study used survey items that the authors had previously validated
(P Reiter, A McRee, J Kadis, N Brewer, unpublished observations,
2010),<sup><xref rid="R19" ref-type="bibr">19</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref></sup> adapted from other
sources,<sup><xref rid="R26" ref-type="bibr">26</xref>&#x02013;<xref rid="R29" ref-type="bibr">29</xref></sup> or newly developed. A
convenience sample of 16 parents of adolescents aged 9&#x02013;17 years
participated in cognitive testing of the survey. Thirty-one parents from the
national panel participated in a pilot test of the survey to ensure proper
survey functionality. The full survey instrument is available online (<ext-link ext-link-type="uri" xlink:href="https://noelbrewer.web.unc.edu/hpv/">noelbrewer.web.unc.edu/hpv/</ext-link>).</p><p id="P17">After the video messages, parents answered several survey items. The
survey assessed parents&#x02019; HPV vaccine hesitancy (3 items,
Cronbach&#x02019;s <italic>&#x003b1;</italic>=0.98): (1) <italic>I am likely to
get my child [the next dose of] the HPV vaccine in the next year</italic>;
(2) <italic>I want to get [the next dose of] the HPV vaccine for my child in the
next year</italic>; and (3) <italic>I plan to get [the next dose of] the HPV
vaccine for my child in the next year</italic>. The 5-point response scales
ranged from <italic>strongly agree</italic> (reverse coded as 1) to
<italic>strongly disagree</italic> (5). The survey also assessed HPV vaccine
confidence, the attitude that a vaccine is effective and safe. The item read:
<italic>Overall, the HPV vaccine will benefit my child&#x02019;s
health</italic>. The 5-point response scale ranged from <italic>strongly
disagree</italic> (1) to <italic>strongly agree</italic> (5). Finally, the
survey assessed perceived vaccine recommendation strength: <italic>How strongly
do you think the doctor in the videos recommends the HPV vaccine for your
child?</italic> The 5-point response scale ranged from <italic>not at
all</italic> (1) to <italic>extremely</italic> (5).</p><p id="P18">Other survey items assessed parents&#x02019; general attitudes toward
vaccines (4 items, <italic>&#x003b1;</italic>=0.84) and trait reactance (3 items,
<italic>&#x003b1;</italic>=0.61).<sup><xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R30" ref-type="bibr">30</xref></sup> The items had
5-point response scales ranging from <italic>strongly disagree</italic> (coded
as 1) to <italic>strongly agree</italic> (5). The survey company provided parent
demographic characteristics including sex, age, race and ethnicity, and
education. The survey asked the parent to report the index child&#x02019;s sex,
age, and HPV vaccinations status (0 doses or &#x02265;1 dose).</p></sec><sec id="S10"><title>Statistical Analysis</title><p id="P19">The authors used 2 &#x000d7; 2 between-subjects factorial ANOVA to
examine the impact of the Ease and Encourage videos (present or absent) on HPV
vaccine hesitancy (<xref rid="F1" ref-type="fig">Figure 1</xref> and <xref rid="T2" ref-type="table">Table 2</xref>). The authors repeated the analyses
using vaccine confidence and perceived recommendation strength as outcomes. For
statistically significant interactions, the authors used the Tukey&#x02013;Kramer
post-hoc test for multiple comparisons, which adjusts for inflation of
family-wise error, deeming studentized ranged statistics (<italic>Q</italic>)
larger than a critical value of 2.77 to be statistically significant.</p><p id="P20">Exploratory analyses used 3-way ANOVA to examine potential moderators
(child&#x02019;s HPV vaccination status, parents&#x02019; general attitude toward
vaccines, and parents&#x02019; trait reactance) of the impact of experimental
factors on vaccine hesitancy, vaccine confidence, and perceived recommendation
strength. Child&#x02019;s HPV vaccination status had statistically significant
2-way interactions with these experimental factors in 2 instances for perceived
recommendation strength, but in all other analyses no moderator had significant
2- or 3-way interactions and thus are not reported in the text (<xref rid="SD1" ref-type="supplementary-material">Appendix 4</xref>).</p><p id="P21">Easing parents&#x02019; concerns about HPV vaccination and encouraging
vaccination may improve their HPV vaccine confidence, which could then decrease
their vaccine hesitancy. Thus, the authors used structural equation modeling to
evaluate whether the main effect of the Ease and Encourage videos on vaccine
hesitancy is mediated through vaccine confidence (<xref rid="F2" ref-type="fig">Figure 2</xref>). Structural equation modeling used full information
maximum likelihood estimation with bootstrapped resampling procedures.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> The authors assessed the
statistical significance of direct and indirect (mediated) paths, reporting
regression coefficients (<inline-formula><mml:math display="inline" id="M2"><mml:mover accent="true"><mml:mi>&#x003b2;</mml:mi><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula>) standardized on the outcomes.</p><p id="P22">The model employed 5,000 random sample draws with replacement from the
existing data set to generate bias-corrected CIs.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Both standardized and unstandardized model estimates appear in <xref rid="SD1" ref-type="supplementary-material">Appendix
5</xref>.</p><p id="P23">The authors used Stata version 16 for data cleaning and conducting
ANOVAs and M<italic>plus</italic>, version 7.4 for structural equation modeling.
All statistical tests were 2-tailed with a critical
<italic>&#x003b1;</italic>=0.05. Bias-corrected CIs that did not contain 0 met
the criteria for statistical significance. Data analysis ended in spring
2020.</p></sec></sec><sec id="S11"><title>RESULTS</title><p id="P24">Parents exposed to Ease video messages reported lower HPV vaccine hesitancy
(mean=2.71, SD=1.29) compared with parents who were not exposed to Ease video
messages (mean=2.97, SD=1.33; <italic>p</italic>&#x0003c;0.001) (<xref rid="T2" ref-type="table">Table 2</xref>). However, the Encourage video did not affect
hesitancy (mean=2.79, SD=1.33 vs mean=2.89, SD=1.30; <italic>p</italic>=0.19). The
interaction between the Ease and Encourage factors was not statistically significant
(<italic>p</italic>=0.30).</p><p id="P25">Parents exposed to Ease video messages reported higher confidence in the
benefit of HPV vaccine (mean=3.61, SD=1.14) compared with parents who were not
exposed to Ease video messages (mean=3.43, SD=1.19; <italic>p</italic>=0.008).
Parents exposed to the Encourage video message reported similar vaccine confidence
(mean=3.53, SD=1.23) compared to parents who were not exposed to the Encourage video
message (mean=3.52, SD=1.10; <italic>p</italic>=0.87). The interaction between the
Ease and Encourage factors was not statistically significant
(<italic>p</italic>=0.85).</p><p id="P26">Parents exposed to Ease and Encourage video messages reported stronger
perceived recommendation strength (both <italic>p</italic>&#x0003c;0.001), qualified
by an interaction between the 2 factors (<italic>p</italic>=0.003). Without the
Encourage video, parents viewing the Ease video perceived a stronger recommendation
(mean=3.53, SD=0.97) than those who did not view the video (mean=3.10, SD=1.14;
<italic>Q</italic>=7.48). However, in the presence of an Encourage video
message, the Ease video messages did not contribute to perceived recommendation
strength (mean=3.79, SD=0.94 vs mean=3.87, SD=0.93; <italic>Q</italic>=1.41) (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><p id="P27">Parents who had higher HPV vaccine confidence after video message exposure
reported lower hesitancy to get their child HPV vaccine (<inline-formula><mml:math display="inline" id="M3"><mml:mover accent="true"><mml:mi>&#x003b2;</mml:mi><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula>= &#x02212;0.740, 95% CI= &#x02212;0.774,
&#x02212;0.703) (<xref rid="F2" ref-type="fig">Figure 2</xref>). The indirect effect
of the Ease video on hesitancy through confidence was negative and statistically
significant (pathway product= &#x02212;0.057, 95% CI= &#x02212;0.098, &#x02212;0.015).
However, the indirect effect of the Encourage video on hesitancy through confidence
was not statistically significant (pathway product= &#x02212;0.004, 95% CI=
&#x02212;0.047, 0.038).</p></sec><sec id="S12"><title>DISCUSSION</title><p id="P28">Using presumptive communication methods like the Announcement Approach
increases HPV vaccine series initiation.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> However, which
aspects of a provider&#x02019;s recommendation affect parents&#x02019; HPV vaccine
hesitancy and confidence is less well understood. In this national experiment
evaluating the communication components of the Announcement Approach, easing
parents&#x02019; concerns led to higher confidence and lower hesitancy to get their
children HPV vaccine. However, encouraging vaccination did not appear to influence
these outcomes when preceded by a presumptive announcement. The results of this
experiment expand upon communication principles the authors previously
recommended<sup><xref rid="R18" ref-type="bibr">18</xref></sup> and produced
a revised Announcement Approach.</p><p id="P29">First, the findings suggest that addressing questions or concerns parents
raise about HPV vaccine (Ease step) is a necessary step of the Announcement
Approach. Parents who received Ease video messages reported lower vaccine hesitancy
compared with parents who did not receive them. Providing additional information
that address HPV vaccination concerns is clearly beneficial for parents whose
children have not initiated the vaccine.<sup><xref rid="R33" ref-type="bibr">33</xref></sup> A previous communication experiment the authors conducted
also suggested that these Ease messages have a positive effect on vaccine confidence
and motivation in parents who had initiated the series for their children.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> However, further investigation is
warranted to better understand and address parent hesitancy. The mediation analysis
showed vaccine confidence may partially explain the relationship between the Ease
video&#x02019;s effect on vaccine hesitancy. Behavior change theories posit that
attitudes like vaccine confidence are predictors of vaccination motivation and
behaviors, and influencing these attitudes could change motivation.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Vaccine confidence is conceptually a
broad construct that includes attitudes or beliefs that the vaccine works, is safe,
and is part of a trustworthy medical system.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Public health and medical authorities prioritize improving
vaccine confidence,<sup><xref rid="R4" ref-type="bibr">4</xref></sup> particularly
as vaccine hesitant parents are more likely to be exposed to vaccine misinformation,
damaging their trust in vaccines.<sup><xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup> Providers are
trusted sources of vaccine information and can play a paramount role in improving
parents&#x02019; confidence in HPV vaccination for their children.</p><p id="P30">Second, the findings suggest that inclusion of the Encourage step can be
left to a provider&#x02019;s discretion when recommending HPV vaccine to hesitant
parents. The Encourage video led to higher ratings of recommendation strength but
did not affect vaccine hesitancy or confidence. The Ease video alone contributed to
perceptions of a strong recommendation but added little to recommendation
perceptions when followed by the Encourage video. The initial announcement may
adequately communicate a provider&#x02019;s expectations that parents should get
their children vaccinated,<sup><xref rid="R5" ref-type="bibr">5</xref></sup> and
thus the Encourage step may not bolster influence on hesitancy and confidence.
However, parents did not appear to interpret a presumptive announcement as a strong
recommendation for the vaccine, something the Encourage video was able to do. Hence,
the provider could use the Encourage step to signal their unambiguous endorsement of
HPV vaccination. For parents who initially decline vaccination during the visit, the
Encourage step may help parents remember the provider&#x02019;s advice and simplify
future visits.</p><p id="P31">Experiment strengths included a large national sample of U.S. parents of
adolescents and a factorial design. Parents evaluated messages presented by video
rather than in writing, which may more closely reflect the clinical experience and
bolster ecological validity.</p><sec id="S13"><title>Limitations</title><p id="P32">Limitations of this experiment include that vaccination hesitancy was as
a proxy for behavior. Although motivations (e.g., intentions, hesitancy) are 1
of the strongest predictors of behavior, barriers to action and other
impediments can reduce the strength of the association,<sup><xref rid="R36" ref-type="bibr">36</xref></sup> thus making it unclear what impact the
Ease and Encourage Steps separately would have on HPV vaccine uptake.
Additionally, interventions that increase parents&#x02019; confidence in HPV
vaccine and reduce hesitancy alone may not increase vaccine uptake; they could
however increase uptake in combination with strong provider recommendations to
get the vaccine, as other studies have shown.<sup><xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref></sup> The
analyses did not use survey weights to yield generalizable point estimates, but
other studies have shown that experiments with convenience samples closely match
those done with nationally representative samples.<sup><xref rid="R37" ref-type="bibr">37</xref></sup> Randomization should have distributed
any tendency for socially desirable responding equally across experimental
conditions.<sup><xref rid="R38" ref-type="bibr">38</xref></sup> The
findings contribute information on the effect of communication components of the
Announcement Approach on HPV vaccine confidence and hesitancy, but future
studies should examine how the communication components affect uptake.
Additionally, future studies should evaluate how provider communication
trainings function in subpopulations (e.g., rural) with lower HPV vaccine
coverage.<sup><xref rid="R1" ref-type="bibr">1</xref></sup></p></sec></sec><sec id="S14"><title>CONCLUSIONS</title><p id="P33">The Announcement Approach gives providers an effective way to communicate
about HPV vaccine that saves time during clinical encounters<sup><xref rid="R39" ref-type="bibr">39</xref></sup> and results in same-day HPV
vaccination.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> The updated
training spends more time teaching the Ease step, given its clear value. If parents
raise a concern about HPV vaccine, a provider can address their concern, thereby
increasing confidence and reducing hesitancy. In addition, the authors now recommend
the Encourage step as an optional measure for providers to use when recommending HPV
vaccine. Ongoing international dissemination of this training will benefit from
these findings and help reduce HPV cancers through increased HPV vaccine uptake.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS1688302-supplement-1.pdf" orientation="portrait" id="d40e644" position="anchor"/></supplementary-material></sec></body><back><ack id="S15"><title>ACKNOWLEDGMENTS</title><p id="P34">This study was funded by the Centers for Disease Control and Prevention
(CDC) (Principal Investigator: Brewer, grant #3U48DP005017-03S6). Margolis&#x02019;
time was supported by a National Cancer Institute (NCI) award (T32 CA057726). This
publication was also supported by Cooperative Agreement #U48 DP005017-01S8 from CDC
and NCI. Funders played no role in: study design; the collection, analysis, and
interpretation of data; the writing of the report; or the decision to submit the
manuscript for publication. The content is solely the responsibility of the authors
and does not necessarily represent the official views of CDC or NCI.</p><p id="P35">Brewer has served as a paid advisor to Merck &#x00026; Co, Inc., Centers for Disease Control and Prevention, and the World Health Organization. No other financial disclosures were reported by the authors of
this paper.</p></ack><fn-group><fn id="FN1"><p id="P36" content-type="publisher-disclaimer">This is a PDF file of an unedited
manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will
undergo copyediting, typesetting, and review of the resulting proof before it is
published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Elam-Evans</surname><given-names>LD</given-names></name>, <name><surname>Yankey</surname><given-names>D</given-names></name>, <name><surname>Singleton</surname><given-names>JA</given-names></name>, <etal/>
<article-title>National, regional, state, and selected local area vaccination
coverage among adolescents aged 13&#x02013;17 years&#x02014;United States,
2019</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>.
<year>2020</year>;<volume>69</volume>(<issue>33</issue>):<fpage>1109</fpage>&#x02013;<lpage>1116</lpage>.
<pub-id pub-id-type="doi">10.15585/mmwr.mm6933a1</pub-id><comment>.</comment><pub-id pub-id-type="pmid">32817598</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="web"><collab>Office of Disease Prevention and
Health Promotion, HHS. Immunizations and Infections Diseases</collab>.
<comment><ext-link ext-link-type="uri" xlink:href="https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases">https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases</ext-link>.
Published</comment>
<year>2019</year>. <comment>Accessed</comment>
<date-in-citation>May 26, 2020</date-in-citation>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Santoli</surname><given-names>JM</given-names></name>, <name><surname>Lindley</surname><given-names>MC</given-names></name>, <name><surname>DeSilva</surname><given-names>MB</given-names></name>, <etal/>
<article-title>Effects of the COVID-19 pandemic on routine pediatric vaccine
ordering and administration&#x02014;United States, 2020</article-title>.
<source>MMWR Morb Mortal Wkly Rep</source>.
<year>2020</year>;<volume>69</volume>(<issue>19</issue>):<fpage>591</fpage>&#x02013;<lpage>593</lpage>.
<pub-id pub-id-type="doi">10.15585/mmwr.mm6919e2</pub-id><comment>.</comment><pub-id pub-id-type="pmid">32407298</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="web"><collab>WHO. Ten threats to global health in
2019</collab>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019">https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019</ext-link>.</comment>
<comment>Published 2019. Accessed</comment>
<date-in-citation>March 16, 2021</date-in-citation>.</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Chapman</surname><given-names>GB</given-names></name>, <name><surname>Rothman</surname><given-names>AJ</given-names></name>, <name><surname>Leask</surname><given-names>J</given-names></name>, <name><surname>Kempe</surname><given-names>A</given-names></name>. <article-title>Increasing vaccination: putting psychological science
into action</article-title>. <source>Psychol Sci Public Interest</source>.
<year>2017</year>;<volume>18</volume>(<issue>3</issue>):<fpage>149</fpage>&#x02013;<lpage>207</lpage>.
<pub-id pub-id-type="doi">10.1177/1529100618760521</pub-id><comment>.</comment><pub-id pub-id-type="pmid">29611455</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Hall</surname><given-names>ME</given-names></name>, <name><surname>Malo</surname><given-names>TL</given-names></name>, <name><surname>Gilkey</surname><given-names>MB</given-names></name>, <name><surname>Quinn</surname><given-names>B</given-names></name>, <name><surname>Lathren</surname><given-names>C</given-names></name>. <article-title>Announcements versus conversations to improve HPV
vaccination coverage: a randomized trial</article-title>.
<source>Pediatrics</source>.
<year>2017</year>;<volume>139</volume>(<issue>1</issue>):<fpage>e20161764</fpage>.
<pub-id pub-id-type="doi">10.1542/peds.2016-1764</pub-id><comment>.</comment><pub-id pub-id-type="pmid">27940512</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Dempsey</surname><given-names>AF</given-names></name>, <name><surname>Pyrznawoski</surname><given-names>J</given-names></name>, <name><surname>Lockhart</surname><given-names>S</given-names></name>, <etal/>
<article-title>Effect of a health care professional communication training
intervention on adolescent human papillomavirus vaccination: a cluster
randomized clinical trial</article-title>. <source>JAMA Pediatr</source>.
<year>2018</year>;<volume>172</volume>(<issue>5</issue>):<fpage>e180016</fpage>.
<pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.0016</pub-id><comment>.</comment><pub-id pub-id-type="pmid">29507952</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Sturm</surname><given-names>L</given-names></name>, <name><surname>Donahue</surname><given-names>K</given-names></name>, <name><surname>Kasting</surname><given-names>M</given-names></name>, <name><surname>Kulkarni</surname><given-names>A</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Zimet</surname><given-names>GD</given-names></name>. <article-title>Pediatrician-parent conversations about human
papillomavirus vaccination: an analysis of audio recordings</article-title>.
<source>J Adolesc Health</source>.
<year>2017</year>;<volume>61</volume>(<issue>2</issue>):<fpage>246</fpage>&#x02013;<lpage>251</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jadohealth.2017.02.006</pub-id><comment>.</comment><pub-id pub-id-type="pmid">28455129</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Opel</surname><given-names>DJ</given-names></name>, <name><surname>Mangione-Smith</surname><given-names>R</given-names></name>, <name><surname>Robinson</surname><given-names>JD</given-names></name>, <etal/>
<article-title>The influence of provider communication behaviors on parental
vaccine acceptance and visit experience</article-title>. <source>Am J Public
Health</source>.
<year>2015</year>;<volume>105</volume>(<issue>10</issue>):<fpage>1998</fpage>&#x02013;<lpage>2004</lpage>.
<pub-id pub-id-type="doi">10.2105/ajph.2014.302425</pub-id><comment>.</comment><pub-id pub-id-type="pmid">25790386</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Opel</surname><given-names>DJ</given-names></name>, <name><surname>Heritage</surname><given-names>J</given-names></name>, <name><surname>Taylor</surname><given-names>JA</given-names></name>, <etal/>
<article-title>The architecture of provider-parent vaccine discussions at health
supervision visits</article-title>. <source>Pediatrics</source>.
<year>2013</year>:<volume>132</volume>(<issue>6</issue>):<fpage>1037</fpage>&#x02013;<lpage>1046</lpage>.
<pub-id pub-id-type="doi">10.1542/peds.2013-2037</pub-id><comment>.</comment><pub-id pub-id-type="pmid">24190677</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="web"><collab>HPV IQ. Training Tools</collab>.
<comment><ext-link ext-link-type="uri" xlink:href="https://www.hpviq.org/communication-training-tools/">https://www.hpviq.org/communication-training-tools/</ext-link>.</comment>
<comment>Published 2020. Accessed</comment>
<date-in-citation>May 23, 2020</date-in-citation>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="web"><collab>National Cancer Institute. Making
effective HPV vaccine recommendations</collab>. <comment><ext-link ext-link-type="uri" xlink:href="https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=26926144">https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=26926144</ext-link>.</comment>
<comment>Published 2020. Accessed</comment>
<date-in-citation>December 15, 2020</date-in-citation>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Michie</surname><given-names>S</given-names></name>, <name><surname>Fixsen</surname><given-names>D</given-names></name>, <name><surname>Grimshaw</surname><given-names>JM</given-names></name>, <name><surname>Eccles</surname><given-names>MP</given-names></name>. <article-title>Specifying and reporting complex behaviour change
interventions: the need for a scientific method</article-title>.
<source>Implement Sci</source>.
<year>2009</year>;<volume>4</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/1748-5908-4-40</pub-id><comment>.</comment><pub-id pub-id-type="pmid">19607700</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="web"><collab>Ipsos. Public Affairs
KnowledgePanel</collab>. <comment><ext-link ext-link-type="uri" xlink:href="https://www.ipsos.com/en-us/solutions/public-affairs/knowledgepanel">https://www.ipsos.com/en-us/solutions/public-affairs/knowledgepanel</ext-link>.</comment>
<comment>Published 2020. Accessed</comment>
<date-in-citation>December 10, 2020</date-in-citation>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="book"><collab>The American Association for Public
Opinion Research</collab>. <source>Standard Definitions: Final Dispositions
of Case Codes and Outcome Rates for Surveys</source>. <edition>9th
edition</edition>. <publisher-name>AAPOR</publisher-name>.
<comment><ext-link ext-link-type="uri" xlink:href="https://www.aapor.org/AAPOR_Main/media/publications/Standard-Definitions20169theditionfinal.pdf">https://www.aapor.org/AAPOR_Main/media/publications/Standard-Definitions20169theditionfinal.pdf</ext-link>.</comment>
<comment>Updated 2016. Accessed</comment>
<date-in-citation>March 9, 2021</date-in-citation>.</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Dimitrov</surname><given-names>DM</given-names></name>, <name><surname>Rumrill</surname><given-names>PD</given-names><suffix>Jr</suffix></name>. <article-title>Pretest&#x02013;posttest designs and measurement of
change</article-title>. <source>Work</source>.
<year>2003</year>;<volume>20</volume>(<issue>2</issue>):<fpage>159</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">12671209</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Calo</surname><given-names>WA</given-names></name>, <name><surname>Gilkey</surname><given-names>MB</given-names></name>, <name><surname>Malo</surname><given-names>TL</given-names></name>, <name><surname>Robichaud</surname><given-names>M</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>. <article-title>A content analysis of HPV vaccination messages available
online</article-title>. <source>Vaccine</source>.
<year>2018</year>;<volume>36</volume>(<issue>49</issue>):<fpage>7525</fpage>&#x02013;<lpage>7529</lpage>.
<pub-id pub-id-type="doi">10.1016/j.vaccine.2018.10.053</pub-id><comment>.</comment><pub-id pub-id-type="pmid">30366803</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Shah</surname><given-names>PD</given-names></name>, <name><surname>Calo</surname><given-names>WA</given-names></name>, <name><surname>Gilkey</surname><given-names>MB</given-names></name>, <etal/>
<article-title>Questions and concerns about HPV vaccine: a communication
experiment</article-title>. <source>Pediatrics</source>.
<year>2019</year>;<volume>143</volume>(<issue>2</issue>):<fpage>e20181872</fpage>.
<pub-id pub-id-type="doi">10.1542/peds.2018-1872</pub-id><comment>.</comment><pub-id pub-id-type="pmid">30670584</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Gilkey</surname><given-names>MB</given-names></name>, <name><surname>Calo</surname><given-names>WA</given-names></name>, <name><surname>Moss</surname><given-names>JL</given-names></name>, <name><surname>Shah</surname><given-names>PD</given-names></name>, <name><surname>Marciniak</surname><given-names>MW</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>. <article-title>Provider communication and HPV vaccination: the impact
of recommendation quality</article-title>. <source>Vaccine</source>.
<year>2016</year>;<volume>34</volume>(<issue>9</issue>):<fpage>1187</fpage>&#x02013;<lpage>1192</lpage>.
<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.01.023</pub-id><comment>.</comment><pub-id pub-id-type="pmid">26812078</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Gilkey</surname><given-names>MB</given-names></name>, <name><surname>Malo</surname><given-names>TL</given-names></name>, <name><surname>Shah</surname><given-names>PD</given-names></name>, <name><surname>Hall</surname><given-names>ME</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>. <article-title>Quality of physician communication about human
papillomavirus vaccine: findings from a national survey</article-title>.
<source>Cancer Epidemiol Biomarkers Prev</source>.
<year>2015</year>;<volume>24</volume>(<issue>11</issue>):<fpage>1673</fpage>&#x02013;<lpage>1679</lpage>.
<pub-id pub-id-type="doi">10.1158/1055-9965.epi-15-0326</pub-id><comment>.</comment><pub-id pub-id-type="pmid">26494764</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Reiter</surname><given-names>PL</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Gottlieb</surname><given-names>SL</given-names></name>, <name><surname>McRee</surname><given-names>A-L</given-names></name>, <name><surname>Smith</surname><given-names>JS</given-names></name>. <article-title>Parents&#x02019; health beliefs and HPV vaccination of
their adolescent daughters</article-title>. <source>Soc Sci Med</source>.
<year>2009</year>;<volume>69</volume>(<issue>3</issue>):<fpage>475</fpage>&#x02013;<lpage>480</lpage>.
<pub-id pub-id-type="doi">10.1016/j.socscimed.2009.05.024</pub-id><comment>.</comment><pub-id pub-id-type="pmid">19540642</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>McRee</surname><given-names>A-L</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Reiter</surname><given-names>PL</given-names></name>, <name><surname>Gottlieb</surname><given-names>SL</given-names></name>, <name><surname>Smith</surname><given-names>JS</given-names></name>. <article-title>The Carolina HPV Immunization Attitudes and Beliefs
Scale (CHIAS): scale development and associations with intentions to
vaccinate</article-title>. <source>Sex Transm Dis</source>.
<year>2010</year>;<volume>37</volume>(<issue>4</issue>):<fpage>234</fpage>&#x02013;<lpage>239</lpage>.
<pub-id pub-id-type="doi">10.1097/olq.0b013e3181c37e15</pub-id><comment>.</comment><pub-id pub-id-type="pmid">19940807</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Gottlieb</surname><given-names>SL</given-names></name>, <name><surname>Reiter</surname><given-names>PL</given-names></name>, <etal/>
<article-title>Longitudinal predictors of HPV vaccine initiation among
adolescent girls in a high-risk geographic area</article-title>. <source>Sex
Transm Dis</source>.
<year>2011</year>;<volume>38</volume>(<issue>3</issue>):<fpage>197</fpage>&#x02013;<lpage>204</lpage>.
<pub-id pub-id-type="doi">10.1097/olq.0b013e3181f12dbf</pub-id><comment>.</comment><pub-id pub-id-type="pmid">20838362</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>McRee</surname><given-names>A-L</given-names></name>, <name><surname>Reiter</surname><given-names>PL</given-names></name>, <name><surname>Gottlieb</surname><given-names>SL</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>. <article-title>Mother&#x02013;daughter communication about HPV
vaccine</article-title>. <source>J Adolesc Health</source>.
<year>2011</year>;<volume>48</volume>(<issue>3</issue>):<fpage>314</fpage>&#x02013;<lpage>317</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jadohealth.2010.07.006</pub-id><comment>.</comment><pub-id pub-id-type="pmid">21338906</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Kornides</surname><given-names>ML</given-names></name>, <name><surname>McRee</surname><given-names>A-L</given-names></name>, <name><surname>Gilkey</surname><given-names>MB</given-names></name>. <article-title>Parents who decline HPV vaccination: Who later accepts
and why?</article-title>
<source>Acad Pediatr</source>.
<year>2018</year>;<volume>18</volume>(<issue>2</issue>):<fpage>S37</fpage>&#x02013;<lpage>S43</lpage>.
<pub-id pub-id-type="doi">10.1016/j.acap.2017.06.008</pub-id><comment>.</comment><pub-id pub-id-type="pmid">29502636</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="web"><collab>CDC. National Immunization
Surveys</collab>. <year>2010</year>
<source>National Immunization Survey &#x02013; Teen: Household Interview
Questionnaire</source>. <comment><ext-link ext-link-type="ftp" xlink:href="ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NIS/NISTEENPUF10_HHQUEX.pdf">ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NIS/NISTEENPUF10_HHQUEX.pdf</ext-link></comment>.
<comment>Accessed</comment>
<date-in-citation>February 22, 2018</date-in-citation>.</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="web"><collab>North Carolina Health and Human
Services. Child Health Assessment and Monitoring Program (CHAMP),
2013&#x02013;14 CHAMP Topics</collab>. <comment><ext-link ext-link-type="uri" xlink:href="https://schs.dph.ncdhhs.gov/data/champ/201314/topics.htm">https://schs.dph.ncdhhs.gov/data/champ/201314/topics.htm</ext-link>.</comment>
<comment>Updated June 26, 2017. Accessed</comment>
<date-in-citation>February 22, 2018</date-in-citation>.</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Hall</surname><given-names>MG</given-names></name>, <name><surname>Sheeran</surname><given-names>P</given-names></name>, <name><surname>Noar</surname><given-names>SM</given-names></name>, <name><surname>Ribisl</surname><given-names>KM</given-names></name>, <name><surname>Boynton</surname><given-names>MH</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>. <article-title>A brief measure of reactance to health
warnings</article-title>. <source>J Behav Med</source>.
<year>2017</year>;<volume>40</volume>(<issue>3</issue>):<fpage>520</fpage>&#x02013;<lpage>529</lpage>.
<pub-id pub-id-type="doi">10.1007/s10865-016-9821-z</pub-id><comment>.</comment><pub-id pub-id-type="pmid">28120228</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Hall</surname><given-names>MG</given-names></name>, <name><surname>Noar</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Effect of pictorial cigarette pack warnings on changes in smoking
behavior: a randomized clinical trial</article-title>. <source>JAMA Intern
Med</source>.
<year>2016</year>;<volume>176</volume>(<issue>7</issue>):<fpage>905</fpage>&#x02013;<lpage>912</lpage>.
<pub-id pub-id-type="doi">10.1001/jamainternmed.2016.2621</pub-id><comment>.</comment><pub-id pub-id-type="pmid">27273839</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Gilkey</surname><given-names>MB</given-names></name>, <name><surname>Magnus</surname><given-names>BE</given-names></name>, <name><surname>Reiter</surname><given-names>PL</given-names></name>, <name><surname>McRee</surname><given-names>A-L</given-names></name>, <name><surname>Dempsey</surname><given-names>AF</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>. <article-title>The Vaccination Confidence Scale: a brief measure of
parents&#x02019; vaccination beliefs</article-title>.
<source>Vaccine</source>.
<year>2014</year>;<volume>32</volume>(<issue>47</issue>):<fpage>6259</fpage>&#x02013;<lpage>6265</lpage>.
<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.09.007</pub-id><comment>.</comment><pub-id pub-id-type="pmid">25258098</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="book"><name><surname>Muth&#x000e9;n</surname><given-names>LK</given-names></name>, <name><surname>Muth&#x000e9;n</surname><given-names>BO</given-names></name>. <source>Mplus User&#x02019;s Guide</source>. <edition>7th
edition</edition>. <publisher-loc>Los Angeles</publisher-loc>,
<publisher-name>CA</publisher-name>.</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>MacKinnon</surname><given-names>DP</given-names></name>, <name><surname>Lockwood</surname><given-names>CM</given-names></name>, <name><surname>Williams</surname><given-names>J</given-names></name>. <article-title>Confidence limits for the indirect effect: distribution
of the product and resampling methods</article-title>. <source>Multivariate
Behav Res</source>.
<year>2004</year>;<volume>39</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>128</lpage>.
<pub-id pub-id-type="doi">10.1207/s15327906mbr3901_4</pub-id><comment>.</comment><pub-id pub-id-type="pmid">20157642</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Dempsey</surname><given-names>A</given-names></name>, <name><surname>Pyrzanowski</surname><given-names>J</given-names></name>, <name><surname>Campagna</surname><given-names>E</given-names></name>, <name><surname>Lockhart</surname><given-names>S</given-names></name>, <name><surname>O&#x02019;Leary</surname><given-names>S</given-names></name>. <article-title>Parent report of provider HPV vaccine communication
strategies used during a randomized, controlled trial of a provider
communication intervention</article-title>. <source>Vaccine</source>.
<year>2019</year>;<volume>37</volume>(<issue>10</issue>):<fpage>1307</fpage>&#x02013;<lpage>1312</lpage>.
<pub-id pub-id-type="doi">10.1016/j.vaccine.2019.01.051</pub-id><comment>.</comment><pub-id pub-id-type="pmid">30733088</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>AM</given-names></name>, <name><surname>Omer</surname><given-names>SB</given-names></name>, <name><surname>Bednarczyk</surname><given-names>RA</given-names></name>, <name><surname>Halsey</surname><given-names>NA</given-names></name>, <name><surname>Moulton</surname><given-names>LH</given-names></name>, <name><surname>Salmon</surname><given-names>DA</given-names></name>. <article-title>Parents&#x02019; source of vaccine information and impact
on vaccine attitudes, beliefs, and nonmedical exemptions</article-title>.
<source>Adv Prev Med</source>.
<year>2012</year>;<volume>2012</volume>:<fpage>932741</fpage>.
<pub-id pub-id-type="doi">10.1155/2012/932741</pub-id><comment>.</comment><pub-id pub-id-type="pmid">23082253</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Teoh</surname><given-names>D</given-names></name>
<article-title>The power of social media for HPV vaccination&#x02013;not fake
news!</article-title>
<source>Am Soc Clin Oncol Educ Book</source>.
<year>2019</year>;<volume>39</volume>:<fpage>75</fpage>&#x02013;<lpage>78</lpage>.
<pub-id pub-id-type="doi">10.1200/EDBK_239363</pub-id><comment>.</comment><pub-id pub-id-type="pmid">31099637</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Sheeran</surname><given-names>P</given-names></name>, <name><surname>Webb</surname><given-names>TL</given-names></name>. <article-title>The intention&#x02013;behavior gap</article-title>.
<source>Soc Personal Psychol Compass</source>.
<year>2016</year>;<volume>10</volume>(<issue>9</issue>):<fpage>503</fpage>&#x02013;<lpage>518</lpage>.
<pub-id pub-id-type="doi">10.1111/spc3.12265</pub-id><comment>.</comment></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Jeong</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>D</given-names></name>, <name><surname>Morgan</surname><given-names>JC</given-names></name>, <etal/>
<article-title>Similarities and differences in tobacco control research findings
from convenience and probability samples</article-title>. <source>Ann Behav
Med</source>.
<year>2019</year>;<volume>53</volume>(<issue>5</issue>):<fpage>476</fpage>&#x02013;<lpage>485</lpage>.
<pub-id pub-id-type="doi">10.1093/abm/kay059</pub-id><comment>.</comment><pub-id pub-id-type="pmid">30052702</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Krumpal</surname><given-names>I</given-names></name>
<article-title>Determinants of social desirability bias in sensitive surveys: a
literature review</article-title>. <source>Qual Quant</source>.
<year>2013</year>;<volume>47</volume>:<fpage>2025</fpage>&#x02013;<lpage>2047</lpage>.
<pub-id pub-id-type="doi">10.1007/s11135-011-9640-9</pub-id><comment>.</comment></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Malo</surname><given-names>TL</given-names></name>, <name><surname>Hall</surname><given-names>ME</given-names></name>, <name><surname>Brewer</surname><given-names>NT</given-names></name>, <name><surname>Lathren</surname><given-names>CR</given-names></name>, <name><surname>Gilkey</surname><given-names>MB</given-names></name>. <article-title>Why is announcement training more effective than
conversation training for introducing HPV vaccination? A theory-based
investigation</article-title>. <source>Implement Sci</source>.
<year>2018</year>;<volume>13</volume>:<fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/s13012-018-0743-8</pub-id><comment>.</comment><pub-id pub-id-type="pmid">29673374</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p id="P37">Interactions between Ease and Encourage factors on perceived
recommendation strength.</p><p id="P38"><italic>Note:</italic> Error bars report SEs.</p></caption><graphic xlink:href="nihms-1688302-f0001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p id="P39">Mediating effect of vaccine confidence between Announcement Approach
steps and HPV vaccine hesitancy.</p><p id="P40"><italic>Note:</italic> Paths show regression coefficients
(<inline-formula><mml:math display="inline" id="M1"><mml:mrow><mml:mover accent="true"><mml:mi>&#x003b2;</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mtext>s</mml:mtext></mml:mrow></mml:math></inline-formula>) standardized on the outcomes. Goodness of fit
tests: &#x003c7;<sup>2</sup>=33; RMSEA=0.062; CFI=0.996; TLI=0.990. Figure omits
factor loadings, residuals, and correlations between variables to simplify
presentation. Dashed pathways were not statistically significant.</p><p id="P41">HPV, human papillomavirus.</p></caption><graphic xlink:href="nihms-1688302-f0002"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1.</label><caption><p id="P42">Parent Characteristics</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1"/><th colspan="5" align="center" valign="middle" rowspan="1">Experimental conditions</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Characteristics</th><th align="center" valign="top" rowspan="1" colspan="1">Overall n (%) or mean (SD)</th><th align="center" valign="top" style="border-top: solid 1px" rowspan="1" colspan="1">A video only
(n=298) n (%) or mean (SD)</th><th align="center" valign="top" style="border-top: solid 1px" rowspan="1" colspan="1">A + ES videos
n (%) or mean (SD)</th><th align="center" valign="top" style="border-top: solid 1px" rowspan="1" colspan="1">A + EN videos
n (%) or mean (SD)</th><th align="center" valign="top" style="border-top: solid 1px" rowspan="1" colspan="1">A + ES + EN
videos n (%) or mean (SD)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>n</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">1,196 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">298 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">300 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">301 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">294 (25)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Parent characteristics</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Sex</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">551 (46)</td><td align="center" valign="middle" rowspan="1" colspan="1">135 (45)</td><td align="center" valign="middle" rowspan="1" colspan="1">135 (45)</td><td align="center" valign="middle" rowspan="1" colspan="1">148 (49)</td><td align="center" valign="middle" rowspan="1" colspan="1">133 (45)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">645 (54)</td><td align="center" valign="middle" rowspan="1" colspan="1">163 (55)</td><td align="center" valign="middle" rowspan="1" colspan="1">168 (55)</td><td align="center" valign="middle" rowspan="1" colspan="1">153 (51)</td><td align="center" valign="middle" rowspan="1" colspan="1">161 (55)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Age</td><td align="center" valign="middle" rowspan="1" colspan="1">42.7 (8.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">42.2 (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">42.7 (7.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">43 (8.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">43.1 (8)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Race/ethnicity</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Non-Hispanic White</td><td align="center" valign="middle" rowspan="1" colspan="1">839 (70)</td><td align="center" valign="middle" rowspan="1" colspan="1">214 (72)</td><td align="center" valign="middle" rowspan="1" colspan="1">214 (70)</td><td align="center" valign="middle" rowspan="1" colspan="1">214 (71)</td><td align="center" valign="middle" rowspan="1" colspan="1">197 (67)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Non-Hispanic Black</td><td align="center" valign="middle" rowspan="1" colspan="1">113 (9)</td><td align="center" valign="middle" rowspan="1" colspan="1">32 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">26 (9)</td><td align="center" valign="middle" rowspan="1" colspan="1">29 (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">26 (9)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Non-Hispanic
multiracial/other</td><td align="center" valign="middle" rowspan="1" colspan="1">79 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (6)</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (5)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (9)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Hispanic</td><td align="center" valign="middle" rowspan="1" colspan="1">165 (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">48 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1">38 (13)</td><td align="center" valign="middle" rowspan="1" colspan="1">46 (16)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Education</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;High school or less</td><td align="center" valign="middle" rowspan="1" colspan="1">325 (27)</td><td align="center" valign="middle" rowspan="1" colspan="1">89 (30)</td><td align="center" valign="middle" rowspan="1" colspan="1">79 (26)</td><td align="center" valign="middle" rowspan="1" colspan="1">81 (27)</td><td align="center" valign="middle" rowspan="1" colspan="1">76 (26)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Some college or more</td><td align="center" valign="middle" rowspan="1" colspan="1">871 (73)</td><td align="center" valign="middle" rowspan="1" colspan="1">209 (70)</td><td align="center" valign="middle" rowspan="1" colspan="1">224 (74)</td><td align="center" valign="middle" rowspan="1" colspan="1">220 (73)</td><td align="center" valign="middle" rowspan="1" colspan="1">218 (74)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Child characteristics</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Sex</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">622 (52)</td><td align="center" valign="middle" rowspan="1" colspan="1">146 (49)</td><td align="center" valign="middle" rowspan="1" colspan="1">169 (56)</td><td align="center" valign="middle" rowspan="1" colspan="1">158 (52)</td><td align="center" valign="middle" rowspan="1" colspan="1">149 (51)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">574 (48)</td><td align="center" valign="middle" rowspan="1" colspan="1">152 (51)</td><td align="center" valign="middle" rowspan="1" colspan="1">134 (44)</td><td align="center" valign="middle" rowspan="1" colspan="1">143 (48)</td><td align="center" valign="middle" rowspan="1" colspan="1">145 (49)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Age</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5 (2.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.4 (2.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5 (2.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.7 (2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.4 (2.6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;HPV vaccination status</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;No doses</td><td align="center" valign="middle" rowspan="1" colspan="1">719 (60)</td><td align="center" valign="middle" rowspan="1" colspan="1">223 (75)</td><td align="center" valign="middle" rowspan="1" colspan="1">207 (68)</td><td align="center" valign="middle" rowspan="1" colspan="1">220 (73)</td><td align="center" valign="middle" rowspan="1" colspan="1">201 (68)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;Initiated series (1
dose)</td><td align="center" valign="middle" rowspan="1" colspan="1">477 (40)</td><td align="center" valign="middle" rowspan="1" colspan="1">75 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">96 (32)</td><td align="center" valign="middle" rowspan="1" colspan="1">81 (27)</td><td align="center" valign="middle" rowspan="1" colspan="1">93 (32)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P43"><italic>Note:</italic> Announcement Approach steps: A=Announce;
ES=Ease; EN=Encourage.</p></fn><fn id="TFN2"><p id="P44">HPV, human papillomavirus.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2.</label><caption><p id="P45">Impact of Ease and Encourage Factors on HPV Vaccine Hesitancy,
Confidence, and Perceived Recommendation Strength</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" valign="bottom" colspan="1">Experimental factors</th><th colspan="3" align="center" valign="middle" style="border-bottom: solid 1px" rowspan="1">Hesitancy to get HPV vaccine
n=1,195</th><th colspan="3" align="center" valign="middle" style="border-bottom: solid 1px" rowspan="1">Vaccine confidence n=1,195</th><th colspan="3" align="center" valign="middle" style="border-bottom: solid 1px" rowspan="1">Perceived recommendation strength
n=1,183</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">df</th><th align="center" valign="bottom" rowspan="1" colspan="1">F</th><th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic></th><th align="center" valign="bottom" rowspan="1" colspan="1">df</th><th align="center" valign="bottom" rowspan="1" colspan="1">F</th><th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic></th><th align="center" valign="bottom" rowspan="1" colspan="1">df</th><th align="center" valign="bottom" rowspan="1" colspan="1">F</th><th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Ease step</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">12.55</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">7.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">19.66</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Encourage step</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.75</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">80.73</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Ease <bold>X</bold> Encourage</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.85</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">9.09</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P46"><italic>Note:</italic> All participants received the Announce video
message.</p></fn><fn id="TFN4"><p id="P47">HPV, human papillomavirus; df, degrees of freedom; F, F test
statistic</p></fn></table-wrap-foot></table-wrap></floats-group></article>